Nhs Says Heart Attack Risk To Be Soon Detectable In Uk

By Charlotte Webster-

Millions of people across England could soon have a new way of finding out whether they are at risk of a heart attack or stroke, as the NHS prepares to introduce seven-minute cholesterol checks at around 100 high-street pharmacies from this autumn.

The new service is part of an ambitious attempt to move cardiovascular disease prevention away from GP surgeries and into the community, allowing eligible people to walk into participating pharmacies for a quick finger-prick test rather than waiting for a routine appointment or blood test.

People aged between 40 and 84 who are not pregnant and have not had a blood test during the previous year will be eligible for the new checks, with the test analysing their cholesterol profile in around seven minutes.

A pharmacist prescriber will then discuss the results with the patient, provide lifestyle advice and determine whether further treatment is appropriate, while a blood-pressure check will also be offered as part of the consultation.

The announcement is significant because high cholesterol can remain unnoticed for years, with many people having no obvious symptoms while fatty deposits gradually build up in the arteries and increase the risk of serious crdiovascular disease.

The NHS is therefore attempting to catch people before they become patients in hospital rather than waiting until a heart attack or stroke forces the issue.

The scale of the problem is considerable. Cardiovascular disease remains one of the country’s major causes of death and illness, and the NHS has set an ambition to reduce deaths from heart disease and stroke by a quarter over the next decade. What makes the announcement particularly interesting is that it is not simply an experiment being launched from scratch.

The national rollout follows a pilot in north London involving Barts Health NHS Trust, UCLPartners and HEART UK, during which 2,493 people were tested at 61 community pharmacies between January 2025 and March 2026. The results provide the clearest indication yet of why the NHS believes the high street could play a much larger role in preventing serious illness.

Of those tested during the pilot, 19 per cent were found to be suitable for pharmacological intervention, while 88 people went on to start statins. UCLPartners says its evidence showed that around one in five people tested were at high risk of suffering a heart attack or stroke within the next ten years.

Those figures give the new programme a sharper significance than simply offering another convenient NHS service. They suggest that putting a test in a familiar high-street setting could uncover a substantial number of people who might otherwise have remained unaware that they were at increased cardiovascular risk.

David Webb, chief pharmaceutical officer for England, said the local pharmacy could become a “vital first line of defence against serious illness”, arguing that quicker access to cholesterol testing could allow problems to be identified earlier and give people an opportunity to act before a heart attack or stroke occurs.

The move is also part of a much bigger change taking place across community pharmacies for decades, the local chemist was primarily associated with prescriptions, cough medicines and advice over minor ailments.

The NHS is now increasingly treating pharmacies as an extension of primary care, with pharmacists taking on more responsibility for assessing patients, providing treatments and, increasingly, prescribing.

A £340 million pharmacy funding deal announced earlier this year is intended to expand the services available on the high street, including the introduction of nationally funded independent prescribing from autumn 2026.

The cholesterol programme therefore represents more than a new test.It is another sign of the NHS trying to change where healthcare happens.Instead of asking patients to navigate an already heavily pressured GP system for every stage of preventive care, the strategy is to put more basic health checks and interventions in places people already visit. That could be particularly important for people who rarely make medical appointments because they feel well.

A person who would ignore a letter inviting them to a health appointment might nevertheless agree to a quick cholesterol test while collecting a prescription or visiting their local pharmacy.The simplicity of the test is central to the proposition.

Rather than a lengthy hospital appointment, the NHS is offering a rapid assessment on the high street, with results available during the consultation and the opportunity for the pharmacist to discuss what they mean.

However, the programme will initially be limited.Around 100 pharmacies will take part in the pilot, which is expected to run until spring 2027, meaning that the service will not immediately be available at every chemist in England.  That limitation will be important because one of the NHS’s stated objectives is to reduce health inequalities.

The people most likely to benefit from early detection are not necessarily those who already have the easiest access to healthcare, and the success of the programme will therefore depend partly on whether participating pharmacies are located in communities where cardiovascular risk is particularly high and whether people who do not routinely engage with healthcare services actually use the opportunity.

Dr Sotiris Antoniou, clinical lead for the north London initiative, said expanding the model could help pharmacists identify cardiovascular risk earlier and act on the results through advice and treatment, with the potential to improve outcomes and reduce health inequalities in communities carrying the greatest burden of cardiovascular disease.

There is also a wider message behind the announcement. The NHS has spent years under pressure to treat people once they become ill, but preventing serious disease before it develops offers the possibility of reducing both human suffering and the demand placed on hospitals.

A seven-minute cholesterol check will not, on its own, solve Britain’s cardiovascular disease problem. It will not eliminate the need for GPs, hospitals or specialist care, and it cannot substitute for healthier diets, exercise, smoking cessation and other measures that influence cardiovascular risk.

One crucial difference this check provides is that it may identify people who have no idea that anything is wrong.  A person standing in a high-street pharmacy may consider seven minutes to be insignificant.

However,  a patient whose test reveals a dangerous cholesterol level and prompts treatment before a blocked artery causes a medical emergency, those seven minutes could prove to be among the most consequential minutes of their year. That is the gamble behind the NHS’s latest attempt to move healthcare closer to home. That catching a problem in the pharmacy is better than meeting it for the first time in an ambulance.